ALX Oncology Holdings Inc. (ALXO)
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States.
$1.98+0.01%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+281.3%
The outlook
ALX Oncology Holdings Inc. currently reads as bullish based on above its 50- & 200-day averages, 68% of the way from its 52-week low to high, avg target +133% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range68% of the way from its 52-week low to high
Price targetAvg target +133% vs current price
Analyst price target
~12-month · 5 analysts$4.60average target+132.9% vs now
Now $1.98
Low $4.00High $6.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$265.8M
52-wk high
$2.66
52-wk low
$0.51
50-day avg
$1.88
200-day avg
$1.76
Trailing P/E
—